and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and...

4

Transcript of and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and...

Page 1: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might
Page 2: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might
Page 3: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might
Page 4: and Immunology/dr_raghu/new... · characterized by a primary or secondary deficit in cellular and humoral immune mechanisms. The oncogenic potential of multimodality therapy might